Age-related gene expression may affect responses to RCC therapyDecember 4, 2018Renal Cell CarcinomaImmunotherapyGenitourinary CancerImmuno-oncology
NICE looks likely to reject use of Kymriah for DLBCLSeptember 24, 2018ImmunotherapyPractice Management
Kymriah cost effectiveness depends on long-term outcomesSeptember 17, 2018Practice ManagementImmunotherapyImmuno-oncology
England green-lights coverage of one CAR T-cell therapySeptember 6, 2018Practice ManagementImmunotherapy
European Commission approves first CAR T-cell therapiesAugust 28, 2018PediatricsLeukemia, Myelodysplasia, TransplantationImmunotherapy
Groups release guidelines for CAR T treatment in childrenAugust 10, 2018ImmunotherapyPediatricsLymphoma & Plasma Cell Disorders
Melanoma survival shorter in those given high dose glucocorticoids for ipilimumab-induced hypophysitisJuly 18, 2018ImmunotherapyMelanomaPatient & Survivor Care
Checkpoint inhibitors in autoimmune disease: More flares, better cancer outcomesJune 25, 2018Immuno-oncologyImmunotherapy
FDA database reveals many rheumatic and musculoskeletal adverse events on immunotherapiesJune 15, 2018Mixed TopicsPatient & Survivor CareImmunotherapy
MRD-negative status signals better outcomes in CAR T–treated ALLJune 5, 2018Immuno-oncologyLeukemia, Myelodysplasia, TransplantationImmunotherapyLymphoma & Plasma Cell Disorders
New ‘immune checkpoint’ vaccine shows promise in treating colorectal cancerMay 25, 2018GastroenterologyImmunotherapyGastrointestinal Cancer
